GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Scaled Net Operating Assets

IMGT (XKRX:456570) Scaled Net Operating Assets : -2.64 (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is IMGT Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

IMGT's operating assets for the quarter that ended in Dec. 2024 was ₩2,116.54 Mil. IMGT's operating liabilities for the quarter that ended in Dec. 2024 was ₩30,024.92 Mil. IMGT's Total Assets for the quarter that ended in Dec. 2023 was ₩10,559.77 Mil. Therefore, IMGT's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was -2.64.


IMGT Scaled Net Operating Assets Historical Data

The historical data trend for IMGT's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT Scaled Net Operating Assets Chart

IMGT Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Scaled Net Operating Assets
-1.94 -4.27 -1.90 -1.61 -2.64

IMGT Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Dec24
Scaled Net Operating Assets -1.94 -4.27 -1.90 -1.61 -2.64

Competitive Comparison of IMGT's Scaled Net Operating Assets

For the Biotechnology subindustry, IMGT's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IMGT's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IMGT's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where IMGT's Scaled Net Operating Assets falls into.


;
;

IMGT Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

IMGT's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2024 )
=(Operating Assets (A: Dec. 2024 )-Operating Liabilities (A: Dec. 2024 ))/Total Assets (A: Dec. 2023 )
=(2116.539-30024.916)/10559.766
=-2.64

where

Operating Assets(A: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=5753.025 - 3636.486
=2116.539

Operating Liabilities(A: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=30189.012 - 37.165 - 126.931
=30024.916

IMGT's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2024 )
=(Operating Assets (Q: Dec. 2024 )-Operating Liabilities (Q: Dec. 2024 ))/Total Assets (Q: Dec. 2023 )
=(2116.539-30024.916)/10559.766
=-2.64

where

Operating Assets(Q: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=5753.025 - 3636.486
=2116.539

Operating Liabilities(Q: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=30189.012 - 37.165 - 126.931
=30024.916

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IMGT Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of IMGT's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


IMGT Business Description

Traded in Other Exchanges
N/A
Address
172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605
IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT Headlines

No Headlines